August 2, 2026 Space-Eyes Goes Public. The Real Question Is Whether It Can Win. Featured: Space-Eyes Goes Public. The Real Question…
Here’s Why Trump Won’t End The Iran War
August 2, 2026 META Breaks Down. MSFT Breaks Out. Featured: META Breaks Down. MSFT Breaks Out. Sponsored Dear Reader, They declared…
GM’s Hybrid Bet Is Hiding in a Corvette
The Grand Sport X is the only hybrid GM sells in the U.S. That says more about electrification credibility than…
Warsh Says Nothing. The Bond Market Says Everything.
August 1, 2026 Warsh Says Nothing. The Bond Market Says Everything. Three dissents, a shorter statement, and 30-year yields near…
Warsh Says Nothing. The Bond Market Says Everything.
August 1, 2026 Warsh Says Nothing. The Bond Market Says Everything. Three dissents, a shorter statement, and 30-year yields near…
Chevron Wins Q2. The Hess Deal Is Why.
A $53 billion acquisition, record US output, and a $4.9 billion downstream swing just separated the two biggest names in…
Intel’s Best Quarter in 15 Years. Down 37%.
August 1, 2026 Intel’s Best Quarter in 15 Years. Down 37%. Featured: Intel’s Best Quarter in 15 Years. Down 37%. Sponsored…
Why Are AI Insiders Dumping Shares?
August 1, 2026 The Insurance Market Already Priced a 2027 Reopening Featured: The Insurance Market Already Priced a 2027 Reopening Sponsored…
AWS Just Grew 37%. The Real Signal Is the Margin.
Amazon raised capex to $220 billion and free cash flow turned negative. The 39% AWS operating margin is why none…
AbbVie Reports Q2 Today. The Post-Humira Story Is Winning.
Skyrizi and Rinvoq have already replaced Humira. The $10.9B Apogee deal adds the next chapter.